Skip to content

Clinical trials

Phase 2 Retinoblastoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinoblastoma Phase: Phase 2 Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20041
20061
20071
20092
20102
20111
20122
20132
20191
20212
20222
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated5
Active, not recruiting3
Recruiting3
Unknown status3
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Memorial Sloan Kettering Cancer Center5
St. Jude Children's Research Hospital3
Institut Curie2
National Cancer Institute (NCI)2
Stanford University2
Ann & Robert H Lurie Children's Hospital of Chicago1
Chengdu Kanghong Biotech Co., Ltd.1
Children's Oncology Group1
Endeavor Biomedicines, Inc.1
Hospital Sant Joan de Deu1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinoblastoma27
Sarcoma8
Neuroblastoma7
Osteosarcoma6
Central Nervous System Neoplasms5
Medulloblastoma4
Ovarian Neoplasms4
Chondrosarcoma3
Desmoplastic Small Round Cell Tumor3
Eye Neoplasms3

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.